NASDAQ:AEZS
AEterna Zentaris Inc. Stock News
$2.08
+0.0800 (+4.00%)
At Close: Mar 27, 2024
Aeterna Zentaris Announced That It Received A Positive Decision From The Listing Qualification Department Of Nasdaq
08:08pm, Thursday, 04'th Jun 2020Aeterna Zentaris Receives Extension From Nasdaq to Satisfy Continuing Listing Requirements
08:05pm, Thursday, 04'th Jun 2020
Aeterna Zentaris Inc. (AEZS) (AEZS) ( the “Company”), a specialty biopharmaceutical company commercializing and developing therapeutics and diagnostic tests, today announced that the Company has r
Aeterna Zentaris Announces Results of 2020 Annual Meeting of Shareholders
08:45pm, Friday, 15'th May 2020
The individuals noted below were elected as Directors of the Company. The Company would like to welcome Peter Edwards to the Board of Directors. The Company would also like to extend its sincere tha
Aeterna Zentaris Announces Results of —…—… Annual Meeting of Shareholders
12:00am, Friday, 15'th May 2020Aeterna Zentaris Announces Virtual 2020 Annual Meeting of Shareholders
01:00pm, Friday, 08'th May 2020
Shareholders will not be able to attend the AGM in-person at a physical location. To be admitted to the virtual AGM, shareholders need to visit www.virtualshareholdermeeting.com/AEZS2020 and enter th
Aeterna Zentaris Announces Virtual —…—… Annual Meeting of Shareholders
12:00am, Friday, 08'th May 202020 Healthcare Stocks Moving In Thursday's Pre-Market Session
12:00am, Thursday, 07'th May 2020AEterna Zentaris Q1 EPS $0.040 Up From $(0.300) YoY, Sales $1.100M Up From $37.000K YoY
12:13pm, Wednesday, 06'th May 2020Aeterna Zentaris Reports First Quarter 2020 Financial and Operating Results
12:05pm, Wednesday, 06'th May 2020
The Company also provided an update on its clinical program to develop macimorelin for the diagnosis of child-onset growth hormone deficiency (“CGHD”), an area of significant unmet need, and its p
One Biotech Stock For 2020
11:30pm, Sunday, 03'rd May 2020
FDA has just fast-tracked research on an exciting new mental health treatment, and one small company is making moves to secure its place as an early mover in this revolution
Gilead's remdesivir will set new standard of care for coronavirus treatment: Dr. Fauci
07:08pm, Thursday, 30'th Apr 2020
Gilead Sciences’ antiviral drug remdesivir showed “quite good news”, according to White House health advisor Dr. Anthony Fauci. Assistant Professor in Department of Health Policy and Management
The Daily Biotech Pulse: FDA Nod For UroGen, Novavax Coronavirus Vaccine To Enter Clinics, Soligenix Licenses Vaccine Adjuvant
12:09pm, Thursday, 16'th Apr 2020
Here's a roundup of top developments in the biotech space over the last 24 hours:Scaling The Peaks (Biotech stocks that hit 52-week highs April 15.) * Bio-Rad Laboratories, Inc. Class B Common Stock
Aeterna Zentaris Receives Nasdaq Notice of Non-Compliance; No Immediate Impact on Listing
08:06pm, Wednesday, 15'th Apr 2020
CHARLESTON, S.C., April 15, 2020 -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) (“Aeterna Zentaris” or the “Company”), a specialty biopharmaceutical company.
Aeterna Zentaris to Present at the April 2020 Virtual Investor Summit
01:15pm, Wednesday, 15'th Apr 2020
A live audio webcast of the presentation will be available on the Events and Presentations page of the Investors section of the Company’s website (www.zentaris.com). The Company’s lead product, M